• Pharma News - All the latest pharmaceutical news from across the web

Search Results for text, 'Roche pharma'

« Page 1 of 206 pages, displaying 1-10 of 2060 results »

Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market 2019 – Roche, GE Healthcare, Merck, Novartis, AMAG Pharmaceuticals

The new research report titled Global Nanoparticles in Biotechnology and Pharmaceuticals Sales Market Analysis 2019 – 2026 offers market status and forecast, categorizes the global Pressure Sensitive Automotive Labels market size by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Ulcerative Colitis Drugs Market to Witness Massive Growth by 2025: Takeda Pharmaceuticals, Roche, Warner Chilcott

A new business intelligence report released by HTF MI with title “Global (United States, European Union and China) Ulcerative Colitis Drugs Market Research Report 2019-2025” is designed covering micro level of analysis by manufacturers and key business segments. The Global (United States, European Union and China) Ulcerative Colitis Drugs Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing. Some of the key players profiled in the study are Johnson & Johnson., AbbVie, Takeda Pharmaceuticals, Roche, Warner Chilcott, Salix Pharmaceuticals/Santarus, Shire Pharmaceuticals, Ferring Pharmaceuticals, Pfizer & InDeX Pharmaceuticals.

Roche Posts Solid Sales for First 9 Months of '19, Ups View

Roche Holding AG RHHBY posted strong sales for the nine months of 2019, propelled by demand for new drugs amid biosimilar competition for legacy drugs. Consequently, the company also raised its guidance for 2019." data-reactid="11">Roche Holding AG RHHBY posted strong sales for the nine months of 2019, propelled by demand for new drugs amid biosimilar competition for legacy drugs. Consequently, the company also raised its guidance for 2019.

Sanofi investing in gene therapy as R&D focus turns toward rare disease

CAMBRIDGE, Mass. — Sanofi is accelerating nascent efforts in gene therapy, aiming to use its expertise in vaccines to catch up in a competitive field that's well ahead of the French pharma.

Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharm – Industry News Info

Developing Revenue in Bronchitis Drug Market 2020 || Advanced Inhalation Therapies (AIT), AstraZeneca Plc, DBV Technologies SA

Business Forecast of Cystic Fibrosis Drugs Market 2020 || Actavis, F. Hoffmann-La Roche, Gilead Sciences

Pharmacovigilance Market By Top Players F. Hoffmann-La Roche, Cognizant, Pharmaceutical Clinical Trial Phase Development, Bristol-Myers Squibb and Forecast 2026 - WeeklySpy

Contrive Datum Insights has published statistical data on global Pharmacovigilance Market. It consists of detailed description about those factors, which are responsible for the growth of the industries. It gives data by analyzing the various terms through the primary and secondary research techniques. In addition to this, it focuses on the recent trends in Pharmacovigilance market. On the basis of features and demand, it offers different application segments. SWOT analysis has been studied to provide different aspects of the businesses along with the different industries.

As Biosimilars Emerge in Oncology and Rare Disease, Innovator Companies Look to New Drugs to Maintain Sales

As innovator biologics that have achieved blockbuster sales status reach or near the end of their exclusivities, biosimilar competition is close behind. This week, stakeholders got a closer look at how innovator drug companies are positioning themselves to maintain their sales in the face of such competition.

For Roche, New Products Help Compensate for Biosimilar Erosion In its third quarter results, Roche reported that its pharmaceuticals division saw its sales increase by 12%, mainly driven by demand for recently launched drugs, including its multiple sclerosis drug ocrelizumab (Ocrevus), its hemophilia A drug emicizumab (Hemlibra), and oncology drugs atezolizumab (Tecentriq) and pertuzumab (Perjeta).

Roche to open new PV HUB on Budapest outskirts

 BBJ

« Page 1 of 206 pages, displaying 1-10 of 2060 results »